Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Malaria vaccine has indirect protective effects

Aug. 21, 2019

Preclinical data presented for the novel re-engineered lupus autoantibody PAT-DX1

Aug. 20, 2019

First-in-human results for the chlamydia vaccine candidate CTH-522

Aug. 20, 2019

Pharmacokinetics and safety data presented from phase I study of EA-230

Aug. 16, 2019

Kezar Life Sciences initiates PRESIDIO and MARINA phase II studies of KZR-616

Aug. 14, 2019

First patient dosed in phase Ib/IIa PREVAIL study of PRV-3279

Aug. 9, 2019

Novel T-cell subtype predicts risk of anaphylactic shock

Aug. 8, 2019

Wild moms are good for offspring microbiome

Aug. 8, 2019

Dosing starts in phase I study of DNL-758

Aug. 6, 2019

Cancer research leads to pregnancy insights

Aug. 5, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...